Split History
ETFs Holding LIFE »    LIFE Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
aTyr Pharma is engaged in the discovery and clinical development of medicines using its knowledge of tRNA synthetase biology. Co. focuses on the therapeutic translation of the Resokine pathway, comprised of extracellular proteins derived from the histidyl tRNA synthetase gene family, which has fueled a pipeline of drug candidate programs addressing disease areas of unmet medical need, including cancer and lung disease. Co.'s programs include: ORCA, which is a preclinical immune-oncology research program that targets the Resokine pathway using antibodies to bind to Resokine in tumor settings; and ATYR1923, which provides designed properties to develop the immuno-modulatory aspects in vivo. According to our LIFE split history records, aTyr Pharma has had 2 splits.
LIFE split history picture
aTyr Pharma (LIFE) has 2 splits in our LIFE split history database. The first split for LIFE took place on July 16, 1991. This was a 3 for 2 split, meaning for each 2 shares of LIFE owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 1500 share position following the split. LIFE's second split took place on December 18, 2003. This was a 2 for 1 split, meaning for each share of LIFE owned pre-split, the shareholder now owned 2 shares. For example, a 1500 share position pre-split, became a 3000 share position following the split.

When a company such as aTyr Pharma splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the LIFE split history from start to finish, an original position size of 1000 shares would have turned into 3000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into aTyr Pharma shares, starting with a $10,000 purchase of LIFE, presented on a split-history-adjusted basis factoring in the complete LIFE split history. LIFE split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/24/2009
End date: 06/21/2019
Start price/share: $40.74
End price/share: $0.39
Dividends collected/share: $0.00
Total return: -99.04%
Average Annual Total Return: -37.15%
Starting investment: $10,000.00
Ending investment: $96.30
Years: 10.00
Date Ratio
07/16/19913 for 2
12/18/20032 for 1
LIFE is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

LJPC Split History
LLY Split History
LPTN Split History
LUX Split History
LXRX Split History
MACK Split History
MBOT Split History
MBVX Split History
MCK Split History
MD Split History

Also explore: LIFE shares outstanding history

Xenetic Biosciences, Inc. (XBIO)
Yuma Energy, Inc. (YUMA)
Avinger, Inc. (AVGR)
Sonoma Pharmaceuticals, Inc. (SOMA)
Hudson Global, Inc. (HSON)
Jaguar Health, Inc. (JAGX)
Cesca Therapeutics Inc. (KOOL)
Northern Technologies International Corporation (NTIC)
Digirad Corporation (DRAD)
Hemispherx Biopharma, Inc. (HEB)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

LIFE Insider Buying

LIFE Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.